Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,061 DKK | +5.91% | +5.45% | -4.36% |
05-03 | GENMAB : A good start to 2024; guidance unchanged | |
05-03 | Genmab Posts Q1 Net Profit Surge; Revenue Jumps | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.36% | 18.05B | |
-1.43% | 103B | |
+8.96% | 101B | |
+4.40% | 23.07B | |
-12.15% | 22.23B | |
-39.98% | 17.18B | |
-10.04% | 16.94B | |
+6.79% | 14.07B | |
+38.61% | 12.35B | |
-24.53% | 8.36B |
- Stock Market
- Equities
- GMAB Stock
- News Genmab A/S
- Genmab A/S : , Bolt Biotherapeutics Partner to Develop Candidate Drugs Against Cancer